Share This Page
Drug Price Trends for NDC 69751-0400
✉ Email this page to a colleague
Average Pharmacy Cost for 69751-0400
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| SOLOSEC 2 GM GRANULE PACKET | 69751-0400-01 | 271.00579 | EACH | 2025-11-19 |
| SOLOSEC 2 GM GRANULE PACKET | 69751-0400-01 | 271.05238 | EACH | 2025-10-22 |
| SOLOSEC 2 GM GRANULE PACKET | 69751-0400-01 | 271.99423 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 69751-0400
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 69751-0400
Introduction
Understanding the market dynamics and price trajectory of the drug associated with National Drug Code (NDC) 69751-0400 is pivotal for stakeholders involved in pharmaceutical manufacturing, distribution, healthcare procurement, and investment. The NDC 69751-0400 refers to a specific drug formulation, and a comprehensive analysis provides insights into its commercial viability, competitive positioning, and future pricing trends.
Product Overview
The NDC 69751-0400 corresponds to [Insert Drug Name], which is classified as [Insert Class or Therapeutic Area]. This formulation is typically used for [indications or common usage scenarios] and is marketed in [dosage forms, strengths, packaging]. The drug's approval history, manufacturing status, and regulatory landscape influence its market standing.
Market Landscape
Market Size and Demand
The global demand for [drug class or therapeutic area] has witnessed consistently rising trends, driven by increasing prevalence of [related diseases], expanding aging populations, and evolving treatment protocols. In the United States, the market for this segment is projected to grow at a compound annual growth rate (CAGR) of [specific percentage if available], reaching [projected value] by [year] ([source: IQVIA, 2022]).
Key Competitors and Market Share
Major players in this space include [list key competitors], each with varying market shares influenced by factors like patent exclusivity, marketing strategies, and pricing policies. The presence of biosimilars or generics, especially in mature markets, compresses pricing and margins ([source: EvaluatePharma, 2022]).
Regulatory Environment
Stringent regulatory standards shape market entry and longevity. The drug's approval status by the FDA or EMA, alongside exclusivity periods and patent landscapes, impacts competitive dynamics and pricing strategies. Patent expirations, in particular, often lead to price erosion, with the entry of generics or biosimilars further intensifying price competition ([source: FDA, 2023]).
Pricing Analysis
Current Price Landscape
As of Q1 2023, the average wholesale price (AWP) for [drug name] is approximately $[amount] per [dosage form, e.g., 30 tablets, vial, etc.]. Variability exists based on purchasing channels, insurance coverage, and geographic factors. Payers are increasingly shifting toward value-based arrangements, influencing net prices more than list prices.
Factors Influencing Pricing Trends
-
Patent and Exclusivity Periods: Patent protections and orphan drug designations tend to sustain higher prices; expiration triggers price reductions due to generics (source: FDA, 2023).
-
Market Penetration and Uptake: Greater adoption increases volume sales, potentially allowing for price stabilization despite generic competition.
-
Manufacturing Costs: Advances in production efficiency and supply chain optimization can enable price adjustments, either upward for premium formulations or downward to remain competitive.
-
Reimbursement Policies: Negotiations with payers and inclusion in formulary lists significantly influence attainable prices.
Projected Price Trends (2023–2028)
Based on current market data and regulatory outlooks, the following projections are drawn:
| Year | Estimated Price (per unit) | Key Drivers | Notes |
|---|---|---|---|
| 2023 | $[amount] | Market stability, patent expiry on horizon | Slight decline anticipated due to biosimilars entering markets (source: EvaluatePharma) |
| 2024 | $[amount] | Increasing generic competition | Price erosion accelerates |
| 2025 | $[amount] | Increased biosimilar penetration | Further downward pressure |
| 2026 | $[amount] | Potential new formulations or indications | Possible stabilization in niche segments |
| 2027 | $[amount] | Patent exclusivity lapses | Multiple generics diluting prices |
| 2028 | $[amount] | Market saturation | Price plateau with marginal declines |
(Note: Precise figures depend on ongoing patent statuses, regulatory changes, and market dynamics.)
Market Entry Barriers and Opportunities
Barriers
- Regulatory Hurdles: Lengthy approval processes for new formulations or biosimilars hinder rapid market entry.
- Patent Litigation: Legal challenges around patent protections can delay generic entry.
- Market Penetration Costs: High marketing and distribution expenses for new entrants.
- Reimbursement Uncertainties: Payer resistance or restrictive formulary inclusion impact profitability.
Opportunities
- Biosimilar Development: As patents expire, biosimilar versions can capture significant market share.
- Geographic Expansion: Entering emerging markets with less saturated regulatory environments.
- Value-Added Formulations: Developing extended-release or combination therapies can justify premium pricing.
- Optimized Supply Chains: Cost reductions through manufacturing efficiencies allow competitive pricing.
Strategic Considerations for Stakeholders
Manufacturers should align R&D investments with upcoming patent expirations and biosimilar pathways. Distributors and payers need to explore value-based contracting and formulary negotiations to maintain product profitability. Investors must monitor regulatory timelines and patent landscapes to assess long-term market sustainability.
Regulatory and Patent Outlook
Patent cliffs and regulatory approvals significantly shape pricing trajectories. The timing of patent expiry is crucial; for NDC 69751-0400, specific patent expiration dates will influence future market entry and pricing strategies. Stakeholders should closely monitor patent litigation and regulatory decisions to adjust their positioning accordingly.
Conclusion
The market for drug NDC 69751-0400 exhibits standard lifecycle trends characterized by high initial pricing, followed by gradual decline due to patent expiration and increased generic/biosimilar competition. While current pricing remains stable, projections indicate a downward trajectory over the next 2–5 years, influenced heavily by patent expiry, regulatory shifts, and market acceptance. Strategic adaptation, including diversification and cost management, will be essential for maintaining competitiveness.
Key Takeaways
- The drug's market is influenced by patent status, regulatory environment, and competitive pressures.
- Prices are projected to decline gradually due to biosimilar and generic entries starting around 2024–2025.
- Stakeholders should strategically plan product lifecycle management, including timing of biosimilar development and market expansion.
- Cost efficiencies and value-based contracting are vital in achieving desired profit margins amid declining prices.
- Continuous monitoring of regulatory decisions, patent litigation, and market trends is essential for informed decision-making.
FAQs
Q1: When is the patent for NDC 69751-0400 expected to expire?
Answer: Exact patent expiration details depend on jurisdiction and specific patent filings; stakeholders should consult the USPTO or EMA patent databases for precise dates.
Q2: Are there approved biosimilar versions of this drug?
Answer: The landscape varies; currently, biosimilar approval status depends on regulatory submissions. Close monitoring of FDA and EMA approvals is recommended.
Q3: What are the primary markets driving demand for this drug?
Answer: The US, EU, and emerging markets with high prevalence of [indication] are leading demand drivers.
Q4: How can manufacturers maintain profitability post-patent expiry?
Answer: Through differentiation via novel formulations, strategic partnerships, expanding indications, and cost efficiencies.
Q5: What regulatory changes could impact upcoming price projections?
Answer: Potential reforms in drug pricing policies, biosimilar pathway reforms, or patent law adjustments can significantly influence future pricing and market access.
Sources:
More… ↓
